| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.807 | 0.003 | 0.807 | Epidermal growth factor receptor kinase inhibitor | 0.766 0.004 CID_135496227 0.671 0.004 CID_11190016 | ||
| 0.799 | 0.003 | 0.799 | ErbB-1 antagonist | 0.78 0.003 CID_135496227 0.724 0.003 CID_11190016 | ||
| 0.794 | 0.005 | 0.794 | Growth factor antagonist | 0.73 0.005 CID_135496227 0.658 0.005 CID_11190016 | ||
| 0.751 | 0.004 | 0.751 | Epidermal growth factor antagonist | 0.712 0.004 CID_135496227 0.633 0.004 CID_11190016 | ||
| 0.679 | 0.002 | 0.679 | EphB4 antagonist | 0.536 0.002 CID_135496227 0.581 0.002 CID_11190016 | ||
| 0.667 | 0.007 | 0.667 | MAP kinase 1 inhibitor | 0.626 0.014 CID_135496227 0.622 0.015 CID_11190016 | ||
| 0.612 | 0.004 | 0.612 | ErbB-2 antagonist | 0.547 0.004 CID_135496227 0.485 0.004 CID_11190016 | ||
| 0.526 | 0.004 | 0.526 | Ephrin antagonist | 0.493 0.004 CID_135496227 0.494 0.004 CID_11190016 | ||
| 0.481 | 0.019 | 0.481 | Tyrosine kinase inhibitor | 0.42 0.026 CID_135496227 0.416 0.026 CID_11190016 | ||
| 0.486 | 0.032 | 0.486 | Angiogenesis inhibitor | 0.452 0.039 CID_135496227 0.457 0.038 CID_11190016 | ||
| 0.456 | 0.01 | 0.456 | Vascular endothelial growth factor antagonist | 0.37 0.015 CID_135496227 0.382 0.015 CID_11190016 | ||
| 0.444 | 0.01 | 0.444 | Vascular endothelial growth factor 2 antagonist | 0.355 0.016 CID_135496227 0.367 0.015 CID_11190016 | ||
| 0.431 | 0.004 | 0.431 | ErbB-4 antagonist | 0.352 0.005 CID_135496227 0.291 0.005 CID_11190016 | ||
| 0.4 | 0.012 | 0.458 | Src kinase inhibitor | 0.382 0.014 CID_135496227 0.458 0.008 CID_11190016 | CID_11190016 | |
| 0.393 | 0.006 | 0.393 | Platelet activating factor beta antagonist | 0.296 0.011 CID_135496227 0.319 0.01 CID_11190016 | ||
| 0.398 | 0.012 | 0.398 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.384 0.014 CID_135496227 0.365 0.017 CID_11190016 | ||
| 0.391 | 0.008 | 0.391 | Aurora-B kinase inhibitor | 0.285 0.017 CID_135496227 0.241 0.022 CID_11190016 | ||
| 0.391 | 0.01 | 0.391 | Vascular endothelial growth factor 3 antagonist | 0.313 0.017 CID_135496227 0.317 0.016 CID_11190016 | ||
| 0.382 | 0.009 | 0.455 | c-Src kinase inhibitor | 0.381 0.009 CID_135496227 0.455 0.005 CID_11190016 | CID_11190016 | |
| 0.383 | 0.02 | 0.383 | Platelet aggregation inhibitor | 0.312 0.033 CID_135496227 0.369 0.023 CID_11190016 | ||
| 0.366 | 0.003 | 0.366 | EphA2 antagonist | 0.331 0.004 CID_135496227 0.337 0.003 CID_11190016 | ||
| 0.381 | 0.019 | 0.381 | EphB2 antagonist | 0.354 0.023 CID_135496227 0.322 0.029 CID_11190016 | ||
| 0.344 | 0.008 | 0.344 | Platelet activating factor antagonist | 0.25 0.017 CID_135496227 0.304 0.011 CID_11190016 | ||
| 0.352 | 0.016 | 0.545 | DNA methylase inhibitor | 0.368 0.014 CID_135496227 0.545 0.005 CID_11190016 | CID_11190016 | |
| 0.312 | 0.004 | 0.312 | ErbB-3 antagonist | 0.279 0.004 CID_135496227 0.264 0.005 CID_11190016 | ||
| 0.322 | 0.018 | 0.322 | RET inhibitor | 0.291 0.024 CID_135496227 0.314 0.02 CID_11190016 | ||
| 0.299 | 0.026 | 0.482 | DNA methyltransferase I inhibitor | 0.312 0.022 CID_135496227 0.482 0.005 CID_11190016 | CID_11190016 | |
| 0.276 | 0.011 | 0.314 | MAP kinase kinase inhibitor | 0.314 0.007 CID_135496227 0.232 0.019 CID_11190016 | CID_135496227 | |
| 0.258 | 0.004 | 0.258 | Fibroblast growth factor 2 antagonist | 0.155 0.01 CID_135496227 0.253 0.004 CID_11190016 | ||
| 0.29 | 0.036 | 0.308 | MAP-kinase-activated kinase 5 inhibitor | 0.308 0.026 CID_135496227 0.295 0.033 CID_11190016 | CID_135496227 | |
| 0.253 | 0.01 | 0.253 | MAP kinase kinase kinase inhibitor | 0.251 0.01 CID_135496227 | ||
| 0.253 | 0.016 | 0.253 | Vascular endothelial growth factor 1 antagonist | 0.216 0.023 CID_135496227 0.229 0.02 CID_11190016 | ||
| 0.368 | 0.132 | 0.404 | Caspase 9 stimulant | 0.371 0.129 CID_135496227 0.404 0.109 CID_11190016 | CID_11190016 | |
| 0.242 | 0.008 | 0.242 | Insulin receptor antagonist | 0.195 0.016 CID_135496227 0.15 0.027 CID_11190016 | ||
| 0.253 | 0.026 | 0.253 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.198 0.037 CID_135496227 0.184 0.041 CID_11190016 | ||
| 0.238 | 0.012 | 0.238 | Platelet activating factor alpha antagonist | 0.176 0.022 CID_135496227 0.215 0.014 CID_11190016 | ||
| 0.267 | 0.049 | 0.267 | Clk dual-specificity kinase inhibitor | 0.24 0.059 CID_135496227 0.251 0.054 CID_11190016 | ||
| 0.25 | 0.037 | 0.25 | Focal adhesion kinase 2 inhibitor | 0.168 0.102 CID_135496227 0.235 0.045 CID_11190016 | ||
| 0.221 | 0.008 | 0.221 | Insulin growth factor antagonist | 0.187 0.013 CID_135496227 0.178 0.015 CID_11190016 | ||
| 0.236 | 0.028 | 0.236 | Lck kinase inhibitor | 0.215 0.035 CID_135496227 0.226 0.031 CID_11190016 | ||
| 0.252 | 0.045 | 0.252 | CDC-like kinase 4 inhibitor | 0.226 0.055 CID_135496227 0.238 0.05 CID_11190016 | ||
| 0.215 | 0.008 | 0.215 | Insulin like growth factor 1 antagonist | 0.17 0.015 CID_135496227 0.154 0.019 CID_11190016 | ||
| 0.254 | 0.058 | 0.254 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.252 0.06 CID_135496227 0.234 0.069 CID_11190016 | ||
| 0.215 | 0.02 | 0.215 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.139 0.037 CID_135496227 0.164 0.029 CID_11190016 | ||
| 0.213 | 0.018 | 0.213 | MAP kinase 3 inhibitor | 0.212 0.019 CID_135496227 0.15 0.067 CID_11190016 | ||
| 0.213 | 0.021 | 0.213 | MAP kinase kinase 5 inhibitor | 0.203 0.03 CID_135496227 0.212 0.022 CID_11190016 | ||
| 0.246 | 0.055 | 0.253 | MAP kinase kinase 2 inhibitor | 0.253 0.052 CID_135496227 0.205 0.079 CID_11190016 | CID_135496227 | |
| 0.222 | 0.038 | 0.222 | Protein-tyrosine kinase Lyn inhibitor | 0.182 0.052 CID_135496227 0.188 0.05 CID_11190016 | ||
| 0.217 | 0.037 | 0.258 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.258 0.027 CID_135496227 0.214 0.038 CID_11190016 | CID_135496227 | |
| 0.187 | 0.011 | 0.187 | Platelet growth factor antagonist | 0.156 0.018 CID_135496227 0.181 0.012 CID_11190016 | ||
| 0.208 | 0.032 | 0.24 | Toll-Like receptor 9 antagonist | 0.141 0.069 CID_135496227 0.24 0.023 CID_11190016 | CID_11190016 | |
| 0.185 | 0.014 | 0.185 | Hepatocyte growth factor antagonist | 0.175 0.016 CID_135496227 0.135 0.027 CID_11190016 | ||
| 0.179 | 0.008 | 0.191 | MAP kinase kinase 1 inhibitor | 0.191 0.005 CID_135496227 0.161 0.013 CID_11190016 | CID_135496227 | |
| 0.178 | 0.012 | 0.178 | AXL receptor tyrosine kinase inhibitor | 0.15 0.017 CID_135496227 0.124 0.025 CID_11190016 | ||
| 0.241 | 0.085 | 0.277 | DNA damaging | 0.254 0.078 CID_135496227 0.277 0.067 CID_11190016 | CID_11190016 | |
| 0.181 | 0.027 | 0.181 | Granulocyte macrophage colony stimulating factor antagonist | 0.097 0.075 CID_135496227 0.098 0.074 CID_11190016 | ||
| 0.211 | 0.059 | 0.217 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.217 0.057 CID_135496227 0.173 0.076 CID_11190016 | CID_135496227 | |
| 0.163 | 0.013 | 0.174 | Raf kinase C inhibitor | 0.174 0.012 CID_135496227 0.136 0.017 CID_11190016 | CID_135496227 | |
| 0.174 | 0.026 | 0.174 | Beta amyloid protein antagonist | 0.137 0.051 CID_135496227 | ||
| 0.188 | 0.043 | 0.188 | CDC-like kinase 1 inhibitor | 0.171 0.054 CID_135496227 0.179 0.049 CID_11190016 | ||
| 0.174 | 0.031 | 0.176 | MAP3K9 inhibitor | 0.171 0.035 CID_135496227 0.176 0.03 CID_11190016 | CID_11190016 | |
| 0.195 | 0.068 | 0.204 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.204 0.064 CID_135496227 0.169 0.082 CID_11190016 | CID_135496227 | |
| 0.141 | 0.014 | 0.141 | Phosphodiesterase 4B inhibitor | 0.065 0.049 CID_11190016 | ||
| 0.165 | 0.04 | 0.165 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.153 0.046 CID_135496227 0.151 0.047 CID_11190016 | ||
| 0.165 | 0.04 | 0.165 | Abl kinase inhibitor | 0.153 0.046 CID_135496227 0.15 0.047 CID_11190016 | ||
| 0.128 | 0.004 | 0.128 | CC chemokine 4 receptor antagonist | 0.08 0.007 CID_135496227 0.099 0.005 CID_11190016 | ||
| 0.149 | 0.025 | 0.149 | Multidrug resistance-associated protein 1 inhibitor | 0.142 0.03 CID_135496227 0.141 0.03 CID_11190016 | ||
| 0.173 | 0.051 | 0.173 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 CID_135496227 0.155 0.063 CID_11190016 | ||
| 0.236 | 0.12 | 0.253 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.253 0.104 CID_135496227 0.233 0.123 CID_11190016 | CID_135496227 | |
| 0.152 | 0.039 | 0.152 | Aurora-A kinase inhibitor | 0.127 0.051 CID_135496227 0.113 0.058 CID_11190016 | ||
| 0.188 | 0.082 | 0.188 | I kappa B kinase epsilon inhibitor | 0.16 0.109 CID_135496227 0.186 0.083 CID_11190016 | ||
| 0.19 | 0.084 | 0.202 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.202 0.075 CID_135496227 0.173 0.101 CID_11190016 | CID_135496227 | |
| 0.143 | 0.047 | 0.143 | MAP kinase 12 inhibitor | 0.138 0.05 CID_135496227 | ||
| 0.133 | 0.046 | 0.133 | MAP kinase 13 inhibitor | 0.131 0.047 CID_135496227 | ||
| 0.118 | 0.031 | 0.125 | Interleukin 12 antagonist | 0.122 0.027 CID_135496227 0.125 0.025 CID_11190016 | CID_11190016 | |
| 0.139 | 0.054 | 0.139 | TRKB antagonist | 0.113 0.083 CID_135496227 | ||
| 0.18 | 0.096 | 0.194 | Antimitotic | 0.151 0.121 CID_135496227 0.194 0.088 CID_11190016 | CID_11190016 | |
| 0.093 | 0.011 | 0.093 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.08 0.017 CID_135496227 0.047 0.035 CID_11190016 | ||
| 0.11 | 0.03 | 0.136 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.11 0.03 CID_135496227 0.136 0.018 CID_11190016 | CID_11190016 | |
| 0.131 | 0.054 | 0.131 | Interleukin 1b antagonist | 0.098 0.083 CID_135496227 | ||
| 0.109 | 0.034 | 0.127 | Bcr-Abl kinase inhibitor | 0.127 0.023 CID_135496227 0.112 0.031 CID_11190016 | CID_135496227 | |
| 0.115 | 0.042 | 0.115 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.107 0.048 CID_135496227 0.113 0.044 CID_11190016 | ||
| 0.221 | 0.15 | 0.221 | Ca(v)3.3 blocker | |||
| 0.091 | 0.021 | 0.091 | ZAP-70 protein tyrosine kinase inhibitor | 0.084 0.03 CID_135496227 0.089 0.024 CID_11190016 | ||
| 0.125 | 0.059 | 0.172 | Protein kinase (CK2) alpha inhibitor | 0.172 0.032 CID_135496227 0.164 0.035 CID_11190016 | CID_135496227 | |
| 0.145 | 0.078 | 0.165 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.142 0.081 CID_135496227 0.165 0.062 CID_11190016 | CID_11190016 | |
| 0.096 | 0.035 | 0.096 | Raf kinase inhibitor | 0.089 0.039 CID_135496227 0.093 0.036 CID_11190016 | ||
| 0.135 | 0.074 | 0.138 | Aurora-C kinase inhibitor | 0.138 0.068 CID_135496227 0.122 0.1 CID_11190016 | CID_135496227 | |
| 0.095 | 0.036 | 0.095 | Phosphodiesterase 11A inhibitor | 0.095 0.037 CID_11190016 | ||
| 0.095 | 0.036 | 0.095 | Phosphodiesterase XI inhibitor | 0.095 0.037 CID_11190016 | ||
| 0.069 | 0.014 | 0.069 | Antiviral (Hepatitis D) | 0.064 0.018 CID_135496227 | ||
| 0.096 | 0.042 | 0.096 | TIE-2 antagonist | 0.081 0.056 CID_135496227 0.074 0.064 CID_11190016 | ||
| 0.097 | 0.043 | 0.097 | TIE antagonist | 0.081 0.058 CID_135496227 0.074 0.066 CID_11190016 | ||
| 0.286 | 0.233 | 0.286 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.075 | 0.022 | 0.075 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.066 | 0.014 | 0.066 | Fructose-1,6-bisphosphatase inhibitor | 0.058 0.019 CID_135496227 0.051 0.024 CID_11190016 | ||
| 0.094 | 0.045 | 0.094 | ALK inhibitor | 0.075 0.067 CID_135496227 0.077 0.063 CID_11190016 | ||
| 0.109 | 0.06 | 0.112 | CDC-like kinase 3 inhibitor | 0.108 0.062 CID_135496227 0.112 0.055 CID_11190016 | CID_11190016 | |
| 0.082 | 0.037 | 0.082 | MAP kinase 7 inhibitor | 0.074 0.071 CID_135496227 0.078 0.053 CID_11190016 | ||
| 0.073 | 0.028 | 0.092 | Phosphodiesterase 1B inhibitor | 0.054 0.051 CID_135496227 0.092 0.017 CID_11190016 | CID_11190016 | |
| 0.101 | 0.057 | 0.101 | Fibroblast growth factor 1 antagonist | 0.091 0.065 CID_11190016 | ||
| 0.063 | 0.019 | 0.067 | Alpha 1L adrenoreceptor antagonist | 0.051 0.039 CID_135496227 0.067 0.014 CID_11190016 | CID_11190016 | |
| 0.1 | 0.061 | 0.1 | mTOR complex 1 inhibitor | 0.097 0.069 CID_135496227 | ||
| 0.154 | 0.116 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.167 0.104 CID_135496227 0.166 0.105 CID_11190016 | CID_135496227 | |
| 0.079 | 0.042 | 0.079 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.138 | 0.102 | 0.152 | CDC-like kinase 2 inhibitor | 0.132 0.108 CID_135496227 0.152 0.092 CID_11190016 | CID_11190016 | |
| 0.158 | 0.123 | 0.166 | Growth factor agonist | 0.166 0.109 CID_135496227 0.155 0.131 CID_11190016 | CID_135496227 | |
| 0.041 | 0.006 | 0.041 | MAP3K8 inhibitor | 0.041 0.006 CID_135496227 | ||
| 0.147 | 0.114 | 0.168 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.158 0.105 CID_135496227 0.168 0.097 CID_11190016 | CID_11190016 | |
| 0.068 | 0.035 | 0.068 | Raf kinase B inhibitor | 0.062 0.039 CID_135496227 0.064 0.037 CID_11190016 | ||
| 0.044 | 0.013 | 0.044 | Potassium channel small-conductance Ca-activated activator | |||
| 0.162 | 0.132 | 0.198 | Antiamyloidogenic | 0.198 0.101 CID_135496227 | CID_135496227 | |
| 0.093 | 0.063 | 0.116 | Breast cancer-resistant protein inhibitor | 0.116 0.042 CID_11190016 | CID_11190016 | |
| 0.09 | 0.061 | 0.097 | Polo-like kinase-1 inhibitor | 0.097 0.05 CID_11190016 | CID_11190016 | |
| 0.062 | 0.038 | 0.062 | CDK9/cyclin T1 inhibitor | 0.057 0.044 CID_135496227 0.054 0.047 CID_11190016 | ||
| 0.082 | 0.058 | 0.082 | Transforming growth factor beta 3 antagonist | 0.08 0.065 CID_135496227 | ||
| 0.081 | 0.061 | 0.092 | T cell inhibitor | 0.08 0.067 CID_135496227 0.092 0.034 CID_11190016 | CID_11190016 | |
| 0.03 | 0.015 | 0.03 | DNA polymerase III inhibitor | 0.03 0.016 CID_135496227 0.029 0.018 CID_11190016 | ||
| 0.077 | 0.061 | 0.077 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.109 | 0.094 | 0.113 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.113 0.09 CID_135496227 | CID_135496227 | |
| 0.097 | 0.082 | 0.097 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.087 CID_11190016 | ||
| 0.069 | 0.056 | 0.069 | MAP kinase 11 inhibitor | |||
| 0.103 | 0.091 | 0.145 | Interleukin 8 antagonist | 0.145 0.037 CID_135496227 | CID_135496227 | |
| 0.04 | 0.029 | 0.05 | DNA-dependent protein kinase inhibitor | 0.038 0.031 CID_135496227 0.05 0.021 CID_11190016 | CID_11190016 | |
| 0.07 | 0.062 | 0.07 | Focal adhesion kinase 1 inhibitor | |||
| 0.085 | 0.078 | 0.142 | Protein kinase (CK2) inhibitor | 0.142 0.037 CID_135496227 0.109 0.056 CID_11190016 | CID_135496227 | |
| 0.106 | 0.101 | 0.106 | Tyrosine-protein kinase receptor antagonist | |||
| 0.081 | 0.076 | 0.109 | Phosphodiesterase I inhibitor | 0.109 0.034 CID_11190016 | CID_11190016 | |
| 0.084 | 0.08 | 0.084 | Phosphodiesterase 7B inhibitor | |||
| 0.11 | 0.106 | 0.11 | Interleukin 1 antagonist | |||
| 0.072 | 0.069 | 0.079 | Phosphodiesterase 3A inhibitor | 0.079 0.057 CID_11190016 | CID_11190016 | |
| 0.144 | 0.142 | 0.222 | Dyrk kinase inhibitor | 0.161 0.126 CID_135496227 0.222 0.086 CID_11190016 | CID_11190016 | |
| 0.103 | 0.101 | 0.164 | Glycogen synthase kinase-3 alpha inhibitor | 0.118 0.086 CID_135496227 0.164 0.057 CID_11190016 | CID_11190016 | |
| 0.107 | 0.105 | 0.11 | DNA repair enzyme inhibitor | 0.107 0.103 CID_135496227 0.11 0.095 CID_11190016 | CID_11190016 | |
| 0.072 | 0.071 | 0.072 | Phosphodiesterase IV inhibitor | |||
| 0.138 | 0.142 | 0.216 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.159 0.123 CID_135496227 0.216 0.083 CID_11190016 | CID_11190016 | |
| 0.06 | 0.068 | 0.083 | Vanilloid antagonist | 0.083 0.045 CID_135496227 | CID_135496227 | |
| 0.236 | 0.248 | 0.318 | 5 Hydroxytryptamine release inhibitor | 0.318 0.146 CID_11190016 | CID_11190016 | |
| 0.08 | 0.097 | 0.084 | Toll-Like receptor 3 antagonist | 0.084 0.083 CID_11190016 | CID_11190016 | |
| 0.127 | 0.149 | 0.137 | ATPase inhibitor | 0.137 0.127 CID_135496227 | CID_135496227 | |
| 0.053 | 0.076 | 0.096 | Phosphodiesterase 5A inhibitor | 0.096 0.028 CID_11190016 | CID_11190016 | |
| 0.12 | 0.144 | 0.149 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.149 0.074 CID_11190016 | CID_11190016 | |
| 0.097 | 0.121 | 0.109 | Ribosomal protein S6 kinase inhibitor | 0.109 0.104 CID_11190016 | CID_11190016 | |
| 0.061 | 0.086 | 0.14 | Macrophage migration inhibitory factor inhibitor | 0.09 0.041 CID_135496227 0.14 0.018 CID_11190016 | CID_11190016 | |
| 0.051 | 0.078 | 0.095 | Phosphodiesterase V inhibitor | 0.095 0.03 CID_11190016 | CID_11190016 | |
| 0.092 | 0.121 | 0.104 | Phosphodiesterase inhibitor | 0.104 0.101 CID_11190016 | CID_11190016 | |
| 0.178 | 0.208 | 0.205 | Caspase 3 stimulant | 0.205 0.162 CID_11190016 | CID_11190016 | |
| 0.048 | 0.081 | 0.076 | Cyclin B3 inhibitor | 0.076 0.041 CID_11190016 | CID_11190016 | |
| 0.173 | 0.209 | 0.268 | Vasodilator, coronary | 0.268 0.117 CID_11190016 | CID_11190016 | |
| 0.041 | 0.08 | 0.054 | Cyclin B1 inhibitor | 0.054 0.051 CID_11190016 | CID_11190016 | |
| 0.036 | 0.075 | 0.05 | Cyclin B2 inhibitor | 0.05 0.047 CID_11190016 | CID_11190016 | |
| 0.125 | 0.167 | 0.145 | Death-associated protein kinase 3 inhibitor | 0.145 0.131 CID_11190016 | CID_11190016 | |
| 0.135 | 0.183 | 0.227 | Cyclic AMP phosphodiesterase inhibitor | 0.227 0.076 CID_11190016 | CID_11190016 | |
| 0.156 | 0.209 | 0.282 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.165 CID_135496227 0.282 0.075 CID_11190016 | CID_11190016 | |
| 0.1 | 0.157 | 0.121 | Farnesoid X receptor antagonist | 0.121 0.102 CID_135496227 | CID_135496227 | |
| 0.055 | 0.112 | 0.085 | Potassium channel (Ca-activated) activator | 0.085 0.07 CID_135496227 | CID_135496227 | |
| 0.051 | 0.126 | 0.076 | Phosphodiesterase VI inhibitor | 0.076 0.048 CID_11190016 | CID_11190016 | |
| 0.038 | 0.128 | 0.126 | Heat shock protein 90 beta antagonist | 0.126 0.006 CID_11190016 | CID_11190016 | |
| 0.046 | 0.14 | 0.081 | Histamine N-methyltransferase inhibitor | 0.081 0.065 CID_11190016 | CID_11190016 | |
| 0.011 | 0.128 | 0.037 | Phosphoglycerate kinase inhibitor | 0.037 0.022 CID_11190016 | CID_11190016 | |
| 0.17 | 0.321 | 0.24 | Apoptosis agonist | 0.24 0.225 CID_11190016 | CID_11190016 | |
| 0.031 | 0.221 | 0.106 | M18 aspartyl aminopeptidase inhibitor | 0.106 0.085 CID_135496227 | CID_135496227 | |
| 0.075 | 0.271 | 0.271 | Aldehyde oxidase inhibitor | 0.271 0.075 CID_11190016 | CID_11190016 | |
| 0.031 | 0.358 | 0.093 | Estrogen receptor beta antagonist | 0.093 0.078 CID_11190016 | CID_11190016 | |
| 0.037 | 0.386 | 0.101 | Estrogen antagonist | 0.101 0.096 CID_11190016 | CID_11190016 | |
| 0.039 | 0.396 | 0.172 | Heat shock protein 90 antagonist | 0.172 0.054 CID_11190016 | CID_11190016 | |
| 0.027 | 0.504 | 0.131 | Heat shock protein 90 alpha antagonist | 0.131 0.11 CID_11190016 | CID_11190016 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |